Glenmark Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

7,891.12

8,220.66

8,141.58

7,567.93

6,712.63

Operating profit

1,241.66

1,472.77

1,688.22

1,890.34

1,304.23

Interest

277.11

206.82

236.04

265.90

256.39

Gross profit

2,132.58

2,251.89

2,066.81

2,020.68

1,654.63

EPS (Rs)

183.11

42.84

70.80

58.46

48.00

Other income

1,168.02

985.94

614.63

396.24

606.79

Stock adjustment

-103.07

-31.37

-16.13

5.24

48.77

Raw material

2,990.41

3,035.88

2,993.04

2,678.26

2,251.98

Power and fuel

-

-

-

-

-

Employee expenses

1,434.78

1,346.51

1,193.20

1,107.40

1,072.33

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

2,327.34

2,396.88

2,283.26

1,886.70

2,035.33

Provisions made

-

-

-

-

-

Depreciation

202.16

184.15

159.70

150.82

138.54

Taxation

1,833.46

363.11

339.66

294.31

180.10

Net profit / loss

5,167.29

1,208.77

1,997.79

1,649.45

1,354.55

Extra ordinary item

5,070.33

-495.87

430.33

73.89

18.55

Prior year adjustments

-

-

-

-

-

Equity capital

28.22

28.22

28.22

28.22

28.22

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

15.73

17.92

20.74

24.98

19.43

GPM (%)

23.54

24.46

23.60

25.37

22.61

NPM (%)

57.04

13.13

22.82

20.71

18.51